Commentary · 21 Feb 2026
Conference abstractPublished 28 Sep 2015
Mesoporous nanoparticles-incorporated temperature-sensitive hydrogel for controlled drug/gene delivery in brain tumor
Institute of Medical Science and Technology, National Sun Yat-sen University, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Malignant brain tumor is a serious disease. Patients treated using surgical resection, radiotherapy and chemotherapy survive, on average, for 6-24 months post-treatment. To date, surgery still is the primary treatment for brain tumor, following with chemotherapy is necessary to prevent the tumor recurrence. However, many potentially effective diagnostic or therapeutic agents are prohibited to deliver into brain by blood-brain barrier (BBB), resulting in the failure of chemotherapy. To overcome the problems, we develop a mesoporous nanoparticles-incorporated temperature-sensitive hydrogel to slowly release drugs and gene in the brain tumor. Our preliminary data showed that hydrogel could be transferred to gel from solution phase while the temperature was raised higher to 32 âÂ?Â? then sustainably released the drugs over three weeks. This delivery system is expected to overcome the BBB, significantly reduce the side-effects and effectively prohibit the growth of residual tumor cells. Keywords: mesoporous nanoparticles, temperature-sensitive hydrogel, brain tumors, drug delivery and gene delivery.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Feng-Wei Lin”
- BylineArticles whose byline prints “Jing-Fong Liao”
- BylineArticles whose byline prints “Hung-Wei Yang”
